Search Results - "Castellón Rubio, V.E"

9426 POSTER Combination Chemotherapy With Gemcitabine and Docetaxel in the Treatment of Metastatic Soft Tissue Sarcomas – a Single Institution Experience by Conde-Herrero, V, González-Rivas, C.S, Soberino, J, Castellón-Rubio, V.E, González-Vicente, A, González-Astorga, B, Luque-Caro, R, Valdivia-Bautista, J, Ortega, J.A, Delgado-Pérez, J.R

Get full text

1118P Retrospective analysis of safety in elderly BRAF V600 mutation-positive advanced melanoma patients treated with dabrafenib (D) and trametinib (T) and correlation with non-elderly patients by García-Castaño, A., González-Barrallo, I., Rubio, V.E. Castellón, Martínez, J. Medina, Mozo, J.L. Manzano, Mujika, K., Tarruella, M. Majem, Aguado de La Rosa, C., Suárez, M.A. Cabrera, Palacio, I., Osterloh, L., Fernandez, A. Martinez

Get full text

385P Thromboembolic events (TE) in patients with metastatic non small cell lung cancer (NSCLC) EGFR / ALK native treated with first-line platinum-based chemotherapy by Castellón Rubio, V.E., Luque Caro, R., Gonzalez Flores, E., Canosa Ruiz, L.

Get full text

1823P Characterization of thrombosis risk in patients with cancer: Preliminary results by Cerezuela, P., García Escobar, I., Salgado, M., Molina, R., Araújo, A., Horváth, E., Porta-Balanya, R., Benitez Montanez, J.C., Lobo de Mena, M., Font, C., Martí, E., Garicano, F., Campos Balea, B., Martínez de Castro, E., Malheiro, M., Costa, A.L., Colomé, E., Castellón Rubio, V.E., Gallardo, E., Trujillo Santos, J.

Get full text

PO-61 Venous thromboembolic disease in cancer patients treated with immunotherapy: analysis of the TESEO study by Ortega Morán, L., Sánchez Cánovas, M., Pérez Altozano, J., Teijeira Sánchez, L., Cumplido Burón, J.D., Gallardo Díaz, E., Antonio Rebollo, M., Ceballos Barbancho, E., Martínez Lago, N., Ortiz Morales, M.J., Castellón Rubio, V.E., Carmona Bayonas, A., Jiménez Fonseca, P., Martínez de Castro, E., Muñoz Langa, J., Pérez Segura, P., Muñoz Martín, A.

Get full text

P-129 Cisplatin plus Gemcitabine in Elderly patients with advanced biliary tract carcinoma: Torrecardenas Hospital Experience by Castellon Rubio, V.E., Gonzalez Cebrian, I., Canosa Ruiz, L.

Get full text

Utilidad de la PET/TAC en la estadificación mediastínica del cáncer de pulmón de células no pequeñas en estadio III (N2) by Sánchez Sánchez, R, Rodríguez Fernández, A, Gómez Río, M, Alkurdi Martínez, A, Castellón Rubio, V.E, Ramos Font, C, Sánchez-Palencia Ramos, A, Delgado Pérez, J.R, Llamas Elvira, J.M

“…Resumen Objetivo Evaluar la validez diagnóstica de la tomografía por emisión de positrones con18 F-fluoro-2-deoxi-D-glucosa y la tomografía computarizada…”
Get full text

Utility of PET/CT for mediastinal staging of non-small cell lung cancer in stage III (N2) by Sánchez Sánchez, R., Rodríguez Fernández, A., Gómez Río, M., Alkurdi Martínez, A., Castellón Rubio, V.E., Ramos Font, C., Sánchez-Palencia Ramos, A., Delgado Pérez, J.R., Llamas Elvira, J.M.

“…To evaluate the accuracy of integrated positron emission tomography with 18F-fluoro-2-deoxy- d-glucose (FDG) and computed tomography (PET/CT) in mediastinal…”
Get full text